Fruchart JC. et al. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM?) paradigm: conceptual framework and therapeutic potential. A consensus statement from the IAS and the R3i Foundation. Cardiovasc Diabetology (2019) 18:71.